Skip to main content
. 2020 Mar 13;11:1364. doi: 10.1038/s41467-020-15186-z

Table 1.

Clinicopathological characteristics of the patients in primary cohort.

All patients (n = 426) Cervical cancer (n = 127) Endometrial cancer (n = 203) Ovarian cancer (n = 96)
n (%) n (%) n (%) n (%)
Age (years) <50 145 (34.0) 73 (57.4) 39 (19.2) 33 (34.3)
≥51 281 (66.0) 54 (42.5) 164 (80.8) 63 (65.6)
FIGO stage I 263 (61.7) 95 (74.8) 114 (56.2) 54 (56.3)
II 58 (13.6) 32 (25.2) 19 (9.4) 7 (7.3)
III 97 (22.8) 0 67 (33.0) 30 (31.3)
IV 8 (1.9) 0 3 (1.5) 5 (5.2)
Histology SCC 63 (49.6)
EAC 167 (82.3)
SAC 24 (25.0)
Others 64 (50.4) 36 (17.7) 72 (75.0)
Peritoneal cytologya Negative 330 (77.5) 127 (100) 155 (76.4) 48 (50.0)
Positive 91 (21.4) 0 (0) 44 (21.7) 47 (49.0)
WBC count (/μL) ≥9000 46 (10.8) 17 (13.4) 17 (8.4) 12 (12.5)
<9000 380 (89.2) 110 (86.6) 186 (91.6) 84 (87.5)

FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, EAC endometrioid adenocarcinoma, SAC serous adenocarcinoma, WBC white blood cell

aPeritoneal cytology was not indicated for 4 cases in endometrial cancer and 1 case in ovarian cancer.